Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RecalMax is a dietary supplement developed by Innovus Pharmaceuticals, formulated to enhance cognitive health and brain function. It consists of a proprietary blend of the amino acids L-arginine and L-citrulline, combined with Bioperine (a black pepper extract) to improve bioavailability. The supplement's primary mechanism of action involves increasing the production of nitric oxide, which acts as a vasodilator to improve cerebral blood flow. This increased circulation is intended to support memory, mental focus, and processing speed, while also mitigating symptoms of mental fatigue. RecalMax is marketed primarily to seniors and individuals concerned with cognitive decline, including those with Alzheimer's disease or dementia. It is available over-the-counter in the United States and is registered as a Natural Health Product in Canada.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RecalMax.